Key Drivers
- Strong Liquidity
- Margin Compression
- Negative Cash Flow
AIAI Summary
MOH is a wait-for-proof investment: despite adequate liquidity, its sub-1% margins, revenue decline, and negative free cash flow mean investors should avoid treating the EPS beat as a recovery until the next earnings report confirms medical-cost stabilization, revenue durability, and sustained cash generation.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Liquidity
- •Margin Compression
- •Negative Cash Flow
MOH has strong liquidity and manageable debt, but thin margins, declining quarterly earnings, negative free cash flow, and elevated latest-quarter valuation warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Support holding
- •Rally resistance
- •Neutral momentum
MOH is range-bound over the last month, with support at $194–$197 but a cautious bias unless it breaks above $205–$207.
Sharp reversal from $214.07 indicates selling pressure on rallies
Sentiment & News
Key News Insights:
- •Contract Expansion
- •Medical Costs
- •Community Support
Molina's growth catalysts remain constructive, but elevated medical costs, valuation risk and recent share weakness warrant caution.
The news is moderately positive for MOH's long-term outlook, though near-term upside may be constrained by cost and valuation concerns
Similar Companies in Healthcare
Other companies in the same sector with AI ratings